SPECIAL EMPHASIS PANELS
To view other meetings from ZAG1 choose calendar year:
| Study Section | Panel Name | Meeting Rosters |
|---|---|---|
| ZAG1 ZIJ-S(O1) | DEMENTIA CAREGIVER SUPPORT INTERVENTION | 05/24/24 |
| ZAG1 ZIJ-1(C2) | GEROSCIENCE-BASED CHRONIC WOUND TREATMENT | 05/23/24 |
| ZAG1 ZIJ-3(C1) | MEX-AD: CHARACTERIZATION OF AD IN THE MEXICAN POPULATION | 05/22/24 |
| ZAG1 ZIJ-P(O2) | AGING AND BONE REGULATION | 05/15/24 |
| ZAG1 ZIJ-P(O3) | COGNITIVE IMPAIRMENT AND AD PREDICTION - II. | 05/08/24 |
| ZAG1 ZIJ-8(M4) | CONSORTIUM FOR ECONOMIC RESEARCH ON AD_ADRD RESEARCH | 04/02/24 |
| ZAG1 ZIJ-6(M2) | BIOMARKERS OF COGNITIVE DECLINE | 03/27/24 |
| ZAG1 ZIJ-S(M4) | STATE DEMENTIA CARE RESEARCH CENTER | 03/25/24 |
| ZAG1 ZIJ-8(M2) | DOMINANTLY INHERITED ALZHEIMER NETWORK | 03/22/24 |
| ZAG1 ZIJ-G(M2) | CLINICAL TRIALS REVIEW | 03/21/24 |
| ZAG1 ZIJ-A(M4) | ALZHEIMER’S DISEASE AND PROTEOLYTIC AND METABOLIC DYSFUNCTION | 03/20/24 |
| ZAG1 ZIJ-3(M4) | INTERDISCIPLINARY AGING INFRASTRUCTURE | 03/20/24 |
| ZAG1 ZIJ-3(M3) | INTERDISCIPLINARY AGING INFRASTRUCTURE | 03/20/24 |
| ZAG1 ZIJ-G(M3) | AD/ADRD MANAGEMENT EVOLUTION | 03/19/24 |
| ZAG1 ZIJ-7(M1) | AGING HORMONE STUDY | 03/19/24 |
| ZAG1 ZIJ-5(M5) | HEALTHCARE DECISION MAKING | 03/18/24 |
| ZAG1 ZIJ-P(C1) | SBIR CONTRACT TOPIC 010 | 03/15/24 |
| ZAG1 ZIJ-I(M1) | REDI SMALL BUSINESS REVIEW PANEL | 03/15/24 |
| ZAG1 ZIJ-A(M2) | BIOMARKERS VALIDATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIA | 03/13/24 |
| ZAG1 ZIJ-D(M2) | AGING TRENDS AND CAREGIVING | 03/12/24 |
| ZAG1 ZIJ-I(M2) | REDI R25 REVIEW PANEL | 03/08/24 |
| ZAG1 ZIJ-6(M1) | K76 BEESON REVIEW | 03/07/24 |
| ZAG1 ZIJ-9(M1) | BEHAVIORAL AND SOCIAL RESEARCH ON IMMIGRATION AND AGING | 03/07/24 |
| ZAG1 ZIJ-A(M3) | ROLE OF TAU OLIGOMER POLYMORPHISM IN ALZHEIMER’S DISEASE AND RELATED DISORDERS | 03/06/24 |
| ZAG1 ZIJ-9(M4) | HEALTH EQUITY AND COST AD/ADRD | 03/05/24 |
| ZAG1 ZIJ-J(M2) | PK/PD OF MTOR INHIBITORS IN AGING | 03/05/24 |
| ZAG1 ZIJ-I(M3) | R01 REVIEW PANEL ON CLONAL HEMATOPOIESIS | 03/04/24 |
| ZAG1 ZIJ-5(M2) | NURSING HOME CLINICAL TRIALS NETWORK | 03/04/24 |
| ZAG1 ZIJ-G(M1) | GAIT AS DEVELOPMENTAL AD MARKER | 03/01/24 |
| ZAG1 ZIJ-9(M2) | BEHAVIORAL AND SOCIAL RESEARCH NETWORKS | 02/29/24 |
| ZAG1 ZIJ-S(M3) | AD/ADRD RESEARCH - RENEWAL AND COMPETING REVISION COOPERATIVE AGREEMENTS | 02/29/24 |
| ZAG1 ZIJ-3(M5) | FETAL PROGRAMMING AND AGING | 02/27/24 |
| ZAG1 ZIJ-9(M3) | SOCIAL AND BEHAVIORAL DETERMINANTS OF HEALTH IN AD/ADRD AND DISPARITIES | 02/27/24 |
| ZAG1 ZIJ-5(M1) | MEASURING FINANCIAL HARDSHIP WITH AD/ADRD | 02/23/24 |
| ZAG1 ZIJ-R(M1) | GEMSSTAR | 02/22/24 |
| ZAG1 ZIJ-J(M4) | ALZHEIMER’S DISEASE SEQUENCING PROJECT | 02/22/24 |
| ZAG1 ZIJ-8(M3) | ADVANCING MOBILE MONITORING OF INTRAINDIVIDUAL CHANGE IN ADRD | 02/22/24 |
| ZAG1 ZIJ-A(M1) | EXERCISE TRAINING IN OLDER ADULTS AND THE PHYSIOLOGIC AND FUNCTIONAL RESPONSES | 02/21/24 |
| ZAG1 ZIJ-2(M2) | BRAIN AGING MODELS | 02/21/24 |
| ZAG1 ZIJ-3(M2) | PRIMATE AGING NETWORKING AND INFRASTRUCTURE | 02/21/24 |
| ZAG1 ZIJ-D(M3) | SEX DIFFERENCES IN AD | 02/15/24 |
| ZAG1 ZIJ-R(M3) | ASPREE-XT RENEWAL REVIEW | 02/15/24 |
| ZAG1 ZIJ-P(M1) | GENE-ENVIRONMENTAL INTERACTIONS ON AGING AND AD-RELATED DEMENTIAS | 02/14/24 |
| ZAG1 ZIJ-P(M3) | IMPACT OF TOXICANTS ON AGING AND AD-RELATED DEMENTIAS | 02/14/24 |
| ZAG1 ZIJ-P(M2) | ENVIRONMENTAL FACTORS ON AGING AND AD-RELATED DEMENTIAS | 02/13/24 |
| ZAG1 ZIJ-G(M4) | MEMBER CONFLICT SEP FOR MID-CAREER AWARDS/CLINICAL CANDIDATES | 02/12/24 |
| ZAG1 ZIJ-S(M5) | BRAIN CELL ATLAS OF AD/ADRD | 02/12/24 |
| ZAG1 ZIJ-J(M1) | TRANSITION TO AGING RESEARCH AWARD FOR PREDOCTORAL STUDENTS | 02/08/24 |
| ZAG1 ZIJ-2(M1) | NAD CT | 02/07/24 |
| ZAG1 ZIJ-R(M2) | FUTURE ADRD PREVENTION WITH INTENSIVE TREATMENT OF HYPERTENSION | 02/02/24 |
| ZAG1 ZIJ-3(M1) | COMPARATIVE PRIMATE AGING AND LONGEVITY | 01/30/24 |
| ZAG1 ZIJ-1(M1) | TREAT-AD | 01/29/24 |
| ZAG1 ZIJ-I(M4) | ALPHA HERPES VIRUSES AND ALZHEIMER'S DISEASE PROGRESSION | 01/26/24 |
| ZAG1 ZIJ-D(M1) | ELDER ABUSE & ADRD | 01/25/24 |
| ZAG1 ZIJ-S(M1) | DEMENTIA CAREGIVER SUPPORT INTERVENTION | 01/22/24 |
| ZAG1 ZIJ-8(M1) | MECHANISMS UNDERLYING HETEROGENEITY OF COGNITIVE OUTCOMES IN SYNUCLEINOPATHY | 01/22/24 |
| ZAG1 ZIJ-S(M2) | SANGHI 3-25-2024 | 01/22/24 |
| ZAG1 ZIJ-1(C3) | MECHANISM-BASED ADULT STEM CELL TREATMENTS FOR AGING PATHOLOGIES | 01/19/24 |
| ZAG1 ZIJ-J(M3) | ALZHEIMER’S DISEASE DRUG DEVELOPMENT | 01/18/24 |
| ZAG1 ZIJ-1(C1) | GENE DELIVERY SYSTEMS FOR AD/ADRD THERAPY DEVELOPMENT | 01/16/24 |
| ZAG1 ZIJ-P(M4) | GENE-ENVIRONMENT INTERPLAY II | 01/09/24 |